In the year 2000, there were an estimated 20 million patients with diabetes. Today that number is around 30 million*. Unfortunately, a serious complication that affects this population’s eye care is not often discussed: Diabetic Retinopathy (DR). In fact, DR is the number one cause of vision loss among people with diabetes but only 50% of those affected are regularly tested**. The focus of this webinar is precisely on how to incorporate point-of-care testing for diabetic retinopathy in practices so you can improve patient outcomes while improving quality measures. We will go over Diabetic Retinopathy symptoms, what the testing for DR at the point of care looks like, the usual barriers to implementation, and the economic side of point-of-care screening.
*Rowley, William & Bezold, Clement & Arikan, Yasemin & Byrne, Erin & Krohe, Shannon. (2016). Diabetes 2030: Insights from Yesterday, Today, and Future Trends. Population health management. 20. 10.1089/pop.2015.0181. **www.cdc.gov/visionhealth/pdf/factsheet.pdf
Speaker: John Bartolovich, CHFP, CSBI — Healthcare Economics and Reimbursement Manager, Topcon Healthcare Solutions